Gaucher Disease Market, Global Outlook and Forecast 2023-2029

Report ID: MMG43832 | Category: Pharma & Healthcare | Pages: 71 | Format: PDF | Published Date: February 21,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Gaucher disease is an inherited disorder that affects many of the body's organs and tissues. The signs and symptoms of this condition vary widely among affected individuals.
This report aims to provide a comprehensive presentation of the global market for Gaucher Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gaucher Disease. This report contains market size and forecasts of Gaucher Disease in global, including the following market information:
Global Gaucher Disease Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Gaucher Disease Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Gaucher Disease companies in 2022 (%)
The global Gaucher Disease market was valued at US$ 1243 million in 2022 and is projected to reach US$ 2175.6 million by 2029, at a CAGR of 8.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Gaucher Disease key players include Sanofi, Takeda, Actelion Pharma, etc. Global top three manufacturers hold a share over 95%.
Europe is the largest market, with a share about 55%, followed by United States and Others, both have a share about 45 percent. 
In terms of product, Enzyme Replacement Therapy is the largest segment, with a share over 90%. And in terms of application, the largest application is Non-neuronopathic Gaucher Disease, followed by Neuronopathic Gaucher Disease.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gaucher Disease manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gaucher Disease Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Gaucher Disease Market Segment Percentages, by Type, 2022 (%)
    Enzyme Replacement Therapy
    Substrate Reduction Therapy
Global Gaucher Disease Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Gaucher Disease Market Segment Percentages, by Application, 2022 (%)
    Non-neuronopathic Gaucher Disease
    Neuronopathic Gaucher Disease
Global Gaucher Disease Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Gaucher Disease Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gaucher Disease revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Gaucher Disease revenues share in global market, 2022 (%)
Key companies Gaucher Disease sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Gaucher Disease sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Sanofi
    Takeda
    Actelion Pharma
    Pfizer (Protalix)
    ISU ABXIS
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gaucher Disease, market overview.
Chapter 2: Global Gaucher Disease market size in revenue and volume.
Chapter 3: Detailed analysis of Gaucher Disease manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gaucher Disease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Gaucher Disease capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Gaucher Disease Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Gaucher Disease Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Gaucher Disease Overall Market Size
    2.1 Global Gaucher Disease Market Size: 2022 VS 2029
    2.2 Global Gaucher Disease Revenue, Prospects & Forecasts: 2018-2029
    2.3 Global Gaucher Disease Sales: 2018-2029
3 Company Landscape
    3.1 Top Gaucher Disease Players in Global Market
    3.2 Top Global Gaucher Disease Companies Ranked by Revenue
    3.3 Global Gaucher Disease Revenue by Companies
    3.4 Global Gaucher Disease Sales by Companies
    3.5 Global Gaucher Disease Price by Manufacturer (2018-2023)
    3.6 Top 3 and Top 5 Gaucher Disease Companies in Global Market, by Revenue in 2022
    3.7 Global Manufacturers Gaucher Disease Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Gaucher Disease Players in Global Market
        3.8.1 List of Global Tier 1 Gaucher Disease Companies
        3.8.2 List of Global Tier 2 and Tier 3 Gaucher Disease Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Gaucher Disease Market Size Markets, 2022 & 2029
        4.1.2 Enzyme Replacement Therapy
        4.1.3 Substrate Reduction Therapy
    4.2 By Type - Global Gaucher Disease Revenue & Forecasts
        4.2.1 By Type - Global Gaucher Disease Revenue, 2018-2023
        4.2.2 By Type - Global Gaucher Disease Revenue, 2024-2029
        4.2.3 By Type - Global Gaucher Disease Revenue Market Share, 2018-2029
    4.3 By Type - Global Gaucher Disease Sales & Forecasts
        4.3.1 By Type - Global Gaucher Disease Sales, 2018-2023
        4.3.2 By Type - Global Gaucher Disease Sales, 2024-2029
        4.3.3 By Type - Global Gaucher Disease Sales Market Share, 2018-2029
    4.4 By Type - Global Gaucher Disease Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Gaucher Disease Market Size, 2022 & 2029
        5.1.2 Non-neuronopathic Gaucher Disease
        5.1.3 Neuronopathic Gaucher Disease
    5.2 By Application - Global Gaucher Disease Revenue & Forecasts
        5.2.1 By Application - Global Gaucher Disease Revenue, 2018-2023
        5.2.2 By Application - Global Gaucher Disease Revenue, 2024-2029
        5.2.3 By Application - Global Gaucher Disease Revenue Market Share, 2018-2029
    5.3 By Application - Global Gaucher Disease Sales & Forecasts
        5.3.1 By Application - Global Gaucher Disease Sales, 2018-2023
        5.3.2 By Application - Global Gaucher Disease Sales, 2024-2029
        5.3.3 By Application - Global Gaucher Disease Sales Market Share, 2018-2029
    5.4 By Application - Global Gaucher Disease Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
    6.1 By Region - Global Gaucher Disease Market Size, 2022 & 2029
    6.2 By Region - Global Gaucher Disease Revenue & Forecasts
        6.2.1 By Region - Global Gaucher Disease Revenue, 2018-2023
        6.2.2 By Region - Global Gaucher Disease Revenue, 2024-2029
        6.2.3 By Region - Global Gaucher Disease Revenue Market Share, 2018-2029
    6.3 By Region - Global Gaucher Disease Sales & Forecasts
        6.3.1 By Region - Global Gaucher Disease Sales, 2018-2023
        6.3.2 By Region - Global Gaucher Disease Sales, 2024-2029
        6.3.3 By Region - Global Gaucher Disease Sales Market Share, 2018-2029
    6.4 North America
        6.4.1 By Country - North America Gaucher Disease Revenue, 2018-2029
        6.4.2 By Country - North America Gaucher Disease Sales, 2018-2029
        6.4.3 US Gaucher Disease Market Size, 2018-2029
        6.4.4 Canada Gaucher Disease Market Size, 2018-2029
        6.4.5 Mexico Gaucher Disease Market Size, 2018-2029
    6.5 Europe
        6.5.1 By Country - Europe Gaucher Disease Revenue, 2018-2029
        6.5.2 By Country - Europe Gaucher Disease Sales, 2018-2029
        6.5.3 Germany Gaucher Disease Market Size, 2018-2029
        6.5.4 France Gaucher Disease Market Size, 2018-2029
        6.5.5 U.K. Gaucher Disease Market Size, 2018-2029
        6.5.6 Italy Gaucher Disease Market Size, 2018-2029
        6.5.7 Russia Gaucher Disease Market Size, 2018-2029
        6.5.8 Nordic Countries Gaucher Disease Market Size, 2018-2029
        6.5.9 Benelux Gaucher Disease Market Size, 2018-2029
    6.6 Asia
        6.6.1 By Region - Asia Gaucher Disease Revenue, 2018-2029
        6.6.2 By Region - Asia Gaucher Disease Sales, 2018-2029
        6.6.3 China Gaucher Disease Market Size, 2018-2029
        6.6.4 Japan Gaucher Disease Market Size, 2018-2029
        6.6.5 South Korea Gaucher Disease Market Size, 2018-2029
        6.6.6 Southeast Asia Gaucher Disease Market Size, 2018-2029
        6.6.7 India Gaucher Disease Market Size, 2018-2029
    6.7 South America
        6.7.1 By Country - South America Gaucher Disease Revenue, 2018-2029
        6.7.2 By Country - South America Gaucher Disease Sales, 2018-2029
        6.7.3 Brazil Gaucher Disease Market Size, 2018-2029
        6.7.4 Argentina Gaucher Disease Market Size, 2018-2029
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Gaucher Disease Revenue, 2018-2029
        6.8.2 By Country - Middle East & Africa Gaucher Disease Sales, 2018-2029
        6.8.3 Turkey Gaucher Disease Market Size, 2018-2029
        6.8.4 Israel Gaucher Disease Market Size, 2018-2029
        6.8.5 Saudi Arabia Gaucher Disease Market Size, 2018-2029
        6.8.6 UAE Gaucher Disease Market Size, 2018-2029
7 Manufacturers & Brands Profiles
    7.1 Sanofi
        7.1.1 Sanofi Company Summary
        7.1.2 Sanofi Business Overview
        7.1.3 Sanofi Gaucher Disease Major Product Offerings
        7.1.4 Sanofi Gaucher Disease Sales and Revenue in Global (2018-2023)
        7.1.5 Sanofi Key News & Latest Developments
    7.2 Takeda
        7.2.1 Takeda Company Summary
        7.2.2 Takeda Business Overview
        7.2.3 Takeda Gaucher Disease Major Product Offerings
        7.2.4 Takeda Gaucher Disease Sales and Revenue in Global (2018-2023)
        7.2.5 Takeda Key News & Latest Developments
    7.3 Actelion Pharma
        7.3.1 Actelion Pharma Company Summary
        7.3.2 Actelion Pharma Business Overview
        7.3.3 Actelion Pharma Gaucher Disease Major Product Offerings
        7.3.4 Actelion Pharma Gaucher Disease Sales and Revenue in Global (2018-2023)
        7.3.5 Actelion Pharma Key News & Latest Developments
    7.4 Pfizer (Protalix)
        7.4.1 Pfizer (Protalix) Company Summary
        7.4.2 Pfizer (Protalix) Business Overview
        7.4.3 Pfizer (Protalix) Gaucher Disease Major Product Offerings
        7.4.4 Pfizer (Protalix) Gaucher Disease Sales and Revenue in Global (2018-2023)
        7.4.5 Pfizer (Protalix) Key News & Latest Developments
    7.5 ISU ABXIS
        7.5.1 ISU ABXIS Company Summary
        7.5.2 ISU ABXIS Business Overview
        7.5.3 ISU ABXIS Gaucher Disease Major Product Offerings
        7.5.4 ISU ABXIS Gaucher Disease Sales and Revenue in Global (2018-2023)
        7.5.5 ISU ABXIS Key News & Latest Developments
8 Global Gaucher Disease Production Capacity, Analysis
    8.1 Global Gaucher Disease Production Capacity, 2018-2029
    8.2 Gaucher Disease Production Capacity of Key Manufacturers in Global Market
    8.3 Global Gaucher Disease Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Gaucher Disease Supply Chain Analysis
    10.1 Gaucher Disease Industry Value Chain
    10.2 Gaucher Disease Upstream Market
    10.3 Gaucher Disease Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Gaucher Disease Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Gaucher Disease Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?